Deep Brain Stimulation Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Deep Brain Stimulation Devices Market is segmented By Product Type, By Application (Parkinson’s Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, and Other Applications), By End User, and Geography.

Market Snapshot

Deep Brain Stimulation Devices Market 1
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 12.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The deep brain stimulation devices market is expected to register a CAGR of nearly 12.5% during the forecast period. The major factors driving the growth of the market include the rapidly aging population, which is leading to risk and high prevalence of neurological disorders, growing demand for the devices, due to the rising popularity of minimally invasive procedures, and availability of technologically advanced deep brain stimulation devices.

  • Deep brain stimulation (DBS) is a widely used treatment for advanced Parkinson's disease (PD), essential tremor, and dystonia. However, over the last three decades, in addition to the extension of its clinical applications, there has been tremendous growth in the DBS technology.
  • According to the World Ageing 2019 report, estimates that there were about 703 million population aged 65 years or over in the world in 2019. This number is projected to double to 1.5 billion in 2050. Moreover, by 2050, 1 in 6 people in the world will be over the age of 65, up from 1 in 11 in 2019. As number of elderly population are projected to increase and this population are more prone to neurological disorders which ultimately drives the market in near future.
  • Currently, there are multiple DBS systems that have been approved by the European and US regulatory agencies. The US Food and Drug Administration (FDA) approved Boston Scientific Corporation’s Vercise Deep Brain Stimulation (DBS) System. This system is used to treat the symptoms of Parkinson's disease (PD). Additionally, researchers are enhancing their existing DBS systems, while developing the next-generation devices.
  • The researchers are using DBS to target different areas of the brain and studying the treatment in different populations suffering from Parkinson’s disease. Some changes in the new systems have shown improvement in clinical outcomes. Nevertheless, these new developments in the DBS technology are encouraging a large patient community and healthcare providers.
  • Hence, all such advancements in the DBS technology have to lead to the growth of the deep brain stimulation devices market.

Scope of the Report

As per the scope of this report, deep brain stimulator is a battery-operated medical device, which is also called neurostimulator. It is used in neurosurgical procedures, to treat a variety of disabling neurological symptoms. The deep brain stimulation devices market is segmented by product type, application, end user, and geography.

By Product Type
Single-channel Deep Brain Stimulator
Dual-channel Deep Brain Stimulator
By Application
Parkinson's Disease
Essential Tremor
Obsessive Compulsive Disorder
Other Applications
By End User
Ambulatory Surgical Centers
Neurological Clinics
Other End Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East & Africa
South Africa
Rest of Middle-East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Parkinson’s Disease Segment is Expected to Hold a Major Market Share in the Deep Brain Stimulation Devices Market

The major factor driving the growth of the segment is the rising global prevalence of Parkinson’s disease. According to Parkinson’s Foundation 2018, approximately 1.2 million people in the United States are estimated to suffer from Parkinson’s disease by 2030. It is the second-most common neurodegenerative disorder in the United States. Similarly, as per the estimates of the NHS UK, Parkinson's disease is found affecting around 1 in 500 people, which means that an estimated 127,000 people in the United Kingdom are suffering from the condition. In addition, there are thousands of patients who go undetected. DBS is the most commonly performed surgical treatment for Parkinson's disease. It is usually done in people, who have been suffering from Parkinson's disease for at least four years and have benefits from medications but have motor complications. Additionally, there is a rising technological advancement in the field of DBS, which is propelling the overall growth of the market.

deep brain key trend 1.png

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

According to the Parkinson’s Foundation Prevalence Project, 930,000 people are estimated to suffer from Parkinson’s disease in the United States, by 2020. The combined direct and indirect costs of Parkinson’s in the United States, including treatment, disability, and similar costs, along with the lost income, owing to the patients’ inability to work, are estimated to be valued at USD 25 billion per year in the United States alone. Hence, the growing burden of Parkinson’s disease on the healthcare system, coupled with uncertain economic conditions in the United States, has forced the original equipment manufacturers (OEMs) to develop cost-effective devices for the treatment of neurological movement disorders. 

The US Food and Drug Administration (FDA) approved a deep brain stimulation (DBS) device, namely Brio System, in 2015, for the treatment of Parkinson’s disease and essential tremor. The Brio System’s approval has been good news for the patient community, as it may stimulate more rapid development of the DBS technology. 

Additionally, Boston Scientific Corporation received approval from the US Food and Drug Administration (FDA) in December 2017, for its Vercise Deep Brain Stimulation (DBS) System. Hence, all such product approvals and growing incidences of the Parkinson’s disease have helped in driving the growth of the deep brain stimulation devices market.

Deep Brain Stimulation Devices Market2

Competitive Landscape

The deep brain stimulation devices market is consolidated, owing to the presence of a few major market players. Some of the market players are Abbott Laboratories (St. Jude Medical), Beijing PINS Medical Co. Ltd, Boston Scientific Corporation, Fisher Wallace, Functional Neuromodulation Ltd, Medtronic PLC, NeuroPace Inc., and Renishaw PLC.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rapidly Aging Population, Leading to Risk and High Prevalence of Neurological Disorders

      2. 4.2.2 Growing Demand for the Devices, Due to Rising Popularity of Minimally Invasive Procedures

      3. 4.2.3 Availability of Technologically Advanced Deep Brain Stimulation Devices

    3. 4.3 Market Restraints

      1. 4.3.1 Risks Associated with Deep Brain Stimulation Procedures

      2. 4.3.2 Implementation of Government Policies Negatively Affecting the Market

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product Type

      1. 5.1.1 Single-channel Deep Brain Stimulator

      2. 5.1.2 Dual-channel Deep Brain Stimulator

    2. 5.2 By Application

      1. 5.2.1 Parkinson's Disease

      2. 5.2.2 Essential Tremor

      3. 5.2.3 Obsessive Compulsive Disorder

      4. 5.2.4 Epilepsy

      5. 5.2.5 Dystonia

      6. 5.2.6 Other Applications

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Neurological Clinics

      4. 5.3.4 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East & Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories (St. Jude Medical)

      2. 6.1.2 Beijing PINS Medical Co. Ltd

      3. 6.1.3 Boston Scientific Corporation

      4. 6.1.4 Fisher Wallace

      5. 6.1.5 Functional Neuromodulation Ltd

      6. 6.1.6 Medtronic PLC

      7. 6.1.7 NeuroPace Inc.

      8. 6.1.8 Renishaw PLC

    2. *List Not Exhaustive

**Competitive Landscape Covers - Business Overview, Financials, Products, Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Deep Brain Stimulation Devices Market market is studied from 2018 - 2026.

The Deep Brain Stimulation Devices Market is growing at a CAGR of 12.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories (St. Jude Medical), Renishaw PLC, NeuroPace Inc. are the major companies operating in Deep Brain Stimulation Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!